LB Abnoba

Company

Our Journey

This is the journey of
LB Abnoba from its inception
to the present day.

2021

~ Now

  • 2024

    • Changed company name to LB Abnoba Co., Ltd.
    • Obtained marketing authorization for Lbracan® Injection

  • 2022

    • Changed company name to Lbridge Abnoba
      (Lbridge, Abnoba Korea corporate merger)
    • Gangwon branch office opened
    • Launched bold fermented bitter gourd

  • 2021

    • Opened the Daegu-Gyeongbuk Branch Office
    • Approved at Severance Hospital for the clinical study on Analysis of the oncological effect of Abnobaviscum administered immediately after surgery in patients with pancreatic cancer who underwent radical pancreatectomy
    • Klimaktoplan Achieved annual sales of 10 million tablets for the first time in Korea
    • Launched three non-reimbursed injection products, including Thymonex, VitaD3nex and Selenex

2011

~ 2020

  • 2020

    • Obtained Gachon University Gil Medical Center IRB approval for the clinical study on effect of mistletoe extract on tumor response in neoadjuvant chemoradiotherapy for rectal cancer
    • Opened the Cheongbuk Branch(Hoseo, Jeonbuk) Office / Opened the Jecheon HRD Institute
    • Concluded a distribution agreement with CureSupport Holding B.V. in Netherlands
    • Approved for government support project for smart factory

  • 2019

    • 20th Anniversary Celebration and announcement of the launch of the LB Group
    • Signed sales contract with Fresenius Kabi Korea for three types of Fresubin.
    • Signed exclusive sales contract with Planttec Medical GmbH Germany
    • Domestic launch of Royal defense & Royal 5000
    • Office relocation to Mullae-dong

  • 2018

    • Opened the Gwangju Jeolla Branch (Honam) Office / Selected as a youth-friendly small company
      (by the Ministry of Employment and Labor)
    • Released German Doppelherz omega-3 in Korea
    • Signed exclusive Distributorship Agreement with Marnys Spain

  • 2017

    • Opened the Busan Gyeongnam Branch(Yeongnam) Office
    • Released German Doppelherz Magnesium 400 in Korea
    • Released Theramune Immune Triple in Korea
    • Entered the health functional foods home shopping market
    • Entered the health functional foods offline store market

  • 2016

    • Signed exclusive supply contract with Queisser Pharma, Germany
    • Launched health functional foods online shop

  • 2015

    • Opened a company-affiliated research institute / Relocated to the SK V1 Center at Dangsan-dong
    • Launched health functional foods

  • 2014

    • Obtained permits for malignant pleural effusion from the Ministry of Food and Drug Safety

  • 2013

    • Approved the Multi-Center Clinical Trial Results for malignant pleural effusion by the Ministry of Food and Drug Safety, (Ulsan University Hospital, Pusan National University Hospital, Hwasun Chonnam National University Hospital, Havelhöhe Hospital, Germany)

  • 2012

    • Registered as a regular member of the Korea Pharmaceutical Association

  • 2011

    • IRB approved for the clinical trial of malignant pleural effusion (Pusan National University Hospital, Ulsan University Hospital, Hwasun Chonnam National University Hospital)
    • Renamed to Lbridge Co., Ltd.

2001

~ 2010

  • 2010

    • Registered the patent for the trade name(Abnoba) and product name (Abnobaviscum)
    • Obtained a clinical license from the Ministry of Food and Drug Safety for the malignant pleural effusion multi-center (Hwasun Chonnam National University Hospital, Pusan National University Hospital, Ulsan University Hospital,Havelhöhe Hospital, Germany)

  • 2009

    • Approved as a business innovation corporation by the Small and Medium Business Administration
    • IRB approval for the gastric cancer clinical study report by Seoul Asan Hospital

  • 2008

    • 2nd office relocation to Ace Highend Tower in Guro-dong
    • Obtained license for the Korea`s first homeopathic medicinal Products, Klimaktoplan® from Ministry of Food and Drug Safety

  • 2007

    • IRB approval for the gastric cancer clinical study by Seoul Asan Hospital
    • Signed exclusive supply agreement with DHU (Deutsche Homöopathie-Union, DHU-ASrzneimittel GmbH & Co.KG), Germany

  • 2005

    • Established Korea Caritas Pharmaceutical Co., Ltd.

  • 2004

    • Relocation to Kolon Digital Tower in Guro-dong
    • Approval of the clinical trial for ovarian cancer at St. Mary`s hospital in Gangnam

  • 2001

    • Acquired drug import licenses from the Ministry
      of Food and Drug Safety (8 items)

1999

~ 2000

  • 2000

    • Changed name to Abnoba Korea Co., Ltd.
    • Approval of the IRB for the clinical trial for ovarian cancer at St. Mary`s hospital in Gangnam
    • Participation of shares by Abnoba, Germany

  • 1999

    • Acquired drug import licenses from the Ministry
      of Food and Drug Safety(6 items)
    • Inauguration of Nam Sang-ok as the CEO of Hyowon Yang-Hang Co., Ltd.
      (Exclusive sales contract with Abnoba, Germany)

1. Purpose of processing personal information LB Abnoba Co., Ltd.,
processes personal information for the following purposes, and does not use it for any purpose other than the following purposes
- To provide consultation services regarding product, quality, distribution, and recruitment inquiries
- To provide consultation results and follow-up actions

2. Processing and retention period of personal information
① LB Abnoba Co., Ltd., processes and retains personal information within the period of possession, and the use of personal information is agreed upon when collecting the personal information from the information subject for within the period of possession according to law.
② Specific personal information processing and retention period are as follows
- Records related to contracts, withdrawals, payments, and supply of goods in e-commerce: 5 years
- Consumer complaints or other consultation records: Retained for 3 years and then destroyed
- If separate retention is required under relevant laws, the information will be retained for the legally prescribed period

3. Provision of personal information to third parties
LB Abnoba Co., Ltd., does not provide personal information to third parties except under the provisions of Article 17 of the Personal Information Protection Act, which includes the informed consent of the data subject and special provisions of the law.

4. Rights, obligations, and method of exercise for the information subject
The information subject may exercise his / her rights related to privacy protection at any time with respect to LB Abnoba Co., Ltd..

1. Request to view personal information
2. Correction request for an error in personal information
3. Deletion request
4. Processing stop request

5. Processed Personal Information Items
The Company processes the following items of personal information:
- Required information: Name, email address, mobile phone number, inquiry type/classification, inquiry details
- Automatically collected items: IP address, cookies, visit records, etc.

6. Destruction of personal information
① The Company destroys personal information without delay when the retention period has expired or when the information becomes unnecessary due to fulfillment of the processing purpose.
② Personal information is destroyed using the following methods:
- Electronic files: Formatting of storage media and deletion from databases
- Handwritten documents : Shred or incinerate

7. Measures to ensure the safety of personal information
LB Abnoba Co., Ltd., takes the following measures to ensure the safety of personal information
- Administrative measures: Establishment and implementation of internal management plans; regular training for employees
- Technical measures: Access control through password settings for systems where personal information is stored; installation of security programs; encryption of files containing personal information
- Physical measures: Access control for servers storing personal information; controlled access to facilities where documents and equipment are stored

8. Personal Information Protection Officer
The Company designates the following Personal Information Protection Officer who is responsible for overseeing personal information processing, addressing complaints, and providing remedies related to personal information.
Personal information protection personnel in charge
Name Jun-young Lee
Department IT Team
Email lbi@lbifamily.com
Contact +82-2-6121-8000

9. Changes to the Privacy Policy
Any changes to the Privacy Policy will be announced through a pop-up notification on the Company’s website.
This Privacy Policy will take effect as of December 1, 2025.

Please be advised that email addresses posted on this website are not collected using e-mail collection programs or other technical devices.

[Posted on July 14, 2016]

Legal Disclaimer and Notice

LB Abnoba reserves all rights of the Services and Materials on the Website.
These services and materials are provided solely for LB Abnoba's customers, for their convenience.
LB Abnoba does not grant intellectual property rights for the services and materials provided to its customers on this site.
LB Abnoba does not guarantee the accuracy, completeness, or reliability of the services, materials, and other information on the site.
Therefore, please do not rely on the information contained on this site as a reference for decisions regarding your interests, except when specifically stated by LB Abnoba through documents. In addition, please do not use the services and materials you provide for any transactions that require purchases, sales, trades, or security. The services and materials are provided on a factual basis by LB Abnoba, and LB Abnoba disclaims any or all warranties, expressed or implied, including, but not limited to, limited warranties for sales purposes or suitability for particular purposes. LB Abnoba assumes no responsibility for any direct, indirect, incidental, punitive, or consequential damages of any kind related to the services and materials.

LB Abnoba's Personal Information on the Internet

LB Abnoba is concerned with the protection of your personal information on the Internet, and the collected personal information may be used in response to your request, by allowing access to certain information. If we have information provided from customers, we may use it to measure the use of this site to improve its content. The specific personal information that LB Abnoba collects from customers when they visit the Lbridge Abnoba sites may be subject to law, to fulfill customer requests or orders, or to protect LB Abnoba from any threats that may violate illegal behavior, fraud, or public safety. Other than above reasons, we do not expose information to the outside

info@lbifamily.com
02-6121-8000
Personal Information Infringement Report Center(118) | Supreme Prosecutors Office(02-3480-2000) | Cyber Terror Response Center(02-393-9112)
http://www.118.or.kr | http://www.spo.go.kr | http://www.ctrc.go.kr